Literature DB >> 19124834

Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens.

Kazutoshi Aoyama1, Motoko Koyama, Ken-ichi Matsuoka, Daigo Hashimoto, Tatsuo Ichinohe, Mine Harada, Koichi Akashi, Mitsune Tanimoto, Takanori Teshima.   

Abstract

Exposure of offspring to noninherited maternal antigens (NIMAs) during pregnancy may have an impact on transplantations performed later in life. Using a mouse model, we recently showed that bone marrow transplantation (BMT) from NIMA-exposed offspring to the mother led to a reduction of graft-versus-host disease (GVHD). Since offspring can also be exposed to NIMAs by breastfeeding after birth, we tested whether breast milk could mediate the tolerogenic NIMA effect. We found that oral exposure to NIMAs by breastfeeding alone was sufficient to reduce GVHD, and that in utero exposure to NIMAs is required for maximum reduction of GVHD. The tolerogenic milk effects disappeared when donor mice were injected with CD25 monoclonal antibodies during the lactation period, suggesting a CD4(+)CD25(+) regulatory T cell-dependent mechanism. Our results suggest a previously unknown impact of breastfeeding on the outcome of transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124834     DOI: 10.1182/blood-2008-05-155283

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

2.  The pendulum swings: Tolerance versus priming to NIMA.

Authors:  Shannon J Opiela; Becky Adkins
Journal:  Chimerism       Date:  2010 Jul-Sep

3.  Breast milk and transplantation tolerance.

Authors:  Kazutoshi Aoyama; Ken-Ichi Matsuoka; Takanori Teshima
Journal:  Chimerism       Date:  2010 Jul-Sep

Review 4.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

5.  Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study.

Authors:  Yu Wang; Xiang-Yu Zhao; Lan-Ping Xu; Xiao-Hui Zhang; Wei Han; Huan Chen; Feng-Rong Wang; Xiao-Dong Mo; Yuan-Yuan Zhang; Xiao-Su Zhao; Kong Y; Kai-Yan Liua; Xiao-Jun Huang; Xue-Zhong Yu; Ying-Jun Chang
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

Review 6.  Oral tolerance.

Authors:  Howard L Weiner; Andre Pires da Cunha; Francisco Quintana; Henry Wu
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 7.  Oral tolerance.

Authors:  Ana M C Faria; Howard L Weiner
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

8.  The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.

Authors:  Julia Pingel; Tao Wang; Yvonne Hagenlocher; Camila J Hernández-Frederick; Arnon Nagler; Michael D Haagenson; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Stephanie J Lee; Mohamad Mohty; Emmanuelle Polge; Stephen R Spellman; Alexander H Schmidt; Jon J van Rood
Journal:  Bone Marrow Transplant       Date:  2018-10-02       Impact factor: 5.483

Review 9.  Tolerance to noninherited maternal antigens in mice and humans.

Authors:  Partha Dutta; William J Burlingham
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

10.  Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice.

Authors:  Partha Dutta; Melanie Molitor-Dart; Joseph L Bobadilla; Drew A Roenneburg; Zhen Yan; Jose R Torrealba; William J Burlingham
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.